Diana Aguilar-Morante
Overview
Explore the profile of Diana Aguilar-Morante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Munoz M, Aguilar-Morante D, Colmenero-Repiso A, Amador-Alvarez A, Ojeda-Puertas M, Cordero Varela J, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675105
Neuroblastoma is a neural crest cell-derived pediatric tumor characterized by high inter- and intra-tumor heterogeneity, and by a poor outcome in advanced stages. Patient-derived xenografts (PDXs) have been shown to...
2.
Gomez-Cabello D, Pappas G, Aguilar-Morante D, Dinant C, Bartek J
Nat Commun
. 2022 Sep;
13(1):5303.
PMID: 36085345
The RNA world is changing our views about sensing and resolution of DNA damage. Here, we develop single-molecule DNA/RNA analysis approaches to visualize how nascent RNA facilitates the repair of...
3.
Lim Y, Jensen K, Aguilar-Morante D, Vardouli L, Vitting-Seerup K, Gimple R, et al.
Neuro Oncol
. 2022 May;
25(2):248-260.
PMID: 35608632
Background: Glioblastoma (GBM) is a highly lethal malignancy for which neoangiogenesis serves as a defining hallmark. The anti-VEGF antibody, bevacizumab, has been approved for the treatment of recurrent GBM, but...
4.
Aguilar-Morante D, Gomez-Cabello D, Quek H, Liu T, Hamerlik P, Lim Y
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203541
Adult diffuse glioma, particularly glioblastoma (GBM), is a devastating tumor of the central nervous system. The existential threat of this disease requires on-going treatment to counteract tumor progression. The present...
5.
Haugaard-Kedstrom L, Clemmensen L, Sereikaite V, Jin Z, Fernandes E, Wind B, et al.
J Med Chem
. 2021 Jan;
64(3):1423-1434.
PMID: 33502198
Despite the recent advances in cancer therapeutics, highly aggressive cancer forms, such as glioblastoma (GBM), still have very low survival rates. The intracellular scaffold protein syntenin, comprising two postsynaptic density...
6.
Obara E, Aguilar-Morante D, Rasmussen R, Frias A, Vitting-Serup K, Lim Y, et al.
Nat Commun
. 2020 Sep;
11(1):4709.
PMID: 32948765
Glioblastoma cancer-stem like cells (GSCs) display marked resistance to ionizing radiation (IR), a standard of care for glioblastoma patients. Mechanisms underpinning radio-resistance of GSCs remain largely unknown. Chromatin state and...
7.
Vega F, Colmenero-Repiso A, Gomez-Munoz M, Rodriguez-Prieto I, Aguilar-Morante D, Ramirez G, et al.
EBioMedicine
. 2020 Mar;
53:102703.
PMID: 32179496
No abstract available.
8.
Vega F, Colmenero-Repiso A, Gomez-Munoz M, Rodriguez-Prieto I, Aguilar-Morante D, Ramirez G, et al.
EBioMedicine
. 2020 Feb;
53:102668.
PMID: 32109836
No abstract available.
9.
Vega F, Colmenero-Repiso A, Gomez-Munoz M, Rodriguez-Prieto I, Aguilar-Morante D, Ramirez G, et al.
EBioMedicine
. 2019 Nov;
49:82-95.
PMID: 31685444
Background: Neuroblastoma is a paediatric tumour originated from sympathoadrenal precursors and characterized by its heterogeneity and poor outcome in advanced stages. Intra-tumoral cellular heterogeneity has emerged as an important feature...
10.
Linares-Clemente P, Aguilar-Morante D, Rodriguez-Prieto I, Ramirez G, de Torres C, Santamaria V, et al.
Oncotarget
. 2017 Nov;
8(52):89775-89792.
PMID: 29163787
Pediatric tumors arise upon oncogenic transformation of stem/progenitor cells during embryonic development. Given this scenario, the existence of non-tumorigenic stem cells included within the aberrant tumoral niche, with a potential...